GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Operating Income

Shanghai INT Medical Instruments Co (HKSE:01501) Operating Income : HK$230.3 Mil (TTM As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Operating Income?

Shanghai INT Medical Instruments Co's Operating Income for the six months ended in Jun. 2024 was HK$102.3 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 was HK$230.3 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Shanghai INT Medical Instruments Co's Operating Income for the six months ended in Jun. 2024 was HK$102.3 Mil. Shanghai INT Medical Instruments Co's Revenue for the six months ended in Jun. 2024 was HK$422.4 Mil. Therefore, Shanghai INT Medical Instruments Co's Operating Margin % for the quarter that ended in Jun. 2024 was 24.21%.

Warning Sign:

Shanghai INT Medical Instruments Co Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -9.7%.

Shanghai INT Medical Instruments Co's 5-Year average Growth Rate for Operating Margin % was -9.70% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Shanghai INT Medical Instruments Co's annualized ROC % for the quarter that ended in Jun. 2024 was 11.76%. Shanghai INT Medical Instruments Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 23.76%.


Shanghai INT Medical Instruments Co Operating Income Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Operating Income Chart

Shanghai INT Medical Instruments Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Income
Get a 7-Day Free Trial Premium Member Only 149.44 140.44 137.55 176.60 229.44

Shanghai INT Medical Instruments Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.38 79.04 97.57 102.27 128.01

Shanghai INT Medical Instruments Co Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$230.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai INT Medical Instruments Co  (HKSE:01501) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Shanghai INT Medical Instruments Co's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=204.538 * ( 1 - 10.45% )/( (1557.076 + 1557.567)/ 2 )
=183.163779/1557.3215
=11.76 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2219.962 - 217.215 - ( 475.133 - max(0, 346.541 - 792.212+475.133))
=1557.076

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2116.293 - 167.883 - ( 390.843 - max(0, 258.162 - 696.773+390.843))
=1557.567

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Shanghai INT Medical Instruments Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=240.674/( ( (893.171 + max(55.034, 0)) + (979.064 + max(98.554, 0)) )/ 2 )
=240.674/( ( 948.205 + 1077.618 )/ 2 )
=240.674/1012.9115
=23.76 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(134.446 + 140.846 + 39.74) - (217.215 + 0 + 42.783)
=55.034

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(80.049 + 165.45 + 55.729) - (167.883 + 0 + 34.791)
=98.554

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Shanghai INT Medical Instruments Co's Operating Margin % for the quarter that ended in Jun. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=102.269/422.352
=24.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Shanghai INT Medical Instruments Co Operating Income Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai INT Medical Instruments Co Business Description

Traded in Other Exchanges
N/A
Address
No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention or implantation and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, The United States and Other countries and regions. The majority of revenue is from the Chinese Mainland.
Executives
China Orient Asset Management (international) Holding Limited 2201 Interest of corporation controlled by you
Zhao Wei 2202 Interest of your spouse
Wang Kai 2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership) 2101 Beneficial owner
Ningbo Huaige Health Investment Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Central Huijin Investment Ltd. 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
Orbimed Capital Llc 2102 Investment manager
Zhao Wei 2202 Interest of your spouse
Zheng Aiping 2501 Other
Zhang Xianmiao 2501 Other
Zhang Wei 2501 Other
Shanghai Kindly Holding Group Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Kindly Enterprise Development Group Co., Ltd. 2101 Beneficial owner

Shanghai INT Medical Instruments Co Headlines

No Headlines